Ingevity Corp buy BMO Capital Markets
Start price
07.08.25
/
50%
€40.88
Target price
07.08.26
€53.17
Performance (%)
25.12%
Price
12.12.25
€51.15
Summary
This prediction is currently active. The prediction currently has a performance of 25.12%. This prediction currently runs until 07.08.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ingevity Corp | 13.264% | 13.264% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by BMO_Capital_Markets for this prediction
In the thread Ingevity Corp diskutieren
Ingevity Corporation (NYSE: NGVT) had its price target raised by analysts at BMO Capital Markets from $56.00 to $62.00. They now have an "outperform" rating on the stock.
Ratings data for NGVT provided by MarketBeat